Paul Omholt

Title: Paul Omholt: Innovative Mind in Gastro-Intestinal Research

Introduction

Paul Omholt, an accomplished inventor based in San Diego, California, has made significant contributions to the field of medical science through his innovative patents. With a strong focus on addressing gastro-intestinal damage and cytokine regulation, his work is instrumental in advancing therapeutic approaches for various health conditions.

Latest Patents

Omholt holds two notable patents that reflect his expertise and innovative thinking. The first patent, titled "Method for Reducing the Severity of Gastro-Intestinal Damage," presents methods for mitigating gastrointestinal damage by administering cytokine regulatory agents to susceptible individuals. This inventive approach aims to harness these agents' therapeutic potential in treating patients impacted by gastrointestinal disorders.

The second patent, "Cytokine Regulatory Agents and Methods of Use in Pathologies," involves novel peptides that serve as potent cytokine regulatory agents. This invention also encompasses pharmaceutical compositions that combine these agents with pharmaceutically acceptable carriers. The methods described in this patent provide a means to enhance or restrain cytokine activity, offering solutions for various medical conditions characterized by abnormal cytokine activity, such as obesity, septic shock, and adverse effects occurring in cancer chemotherapy or organ transplantation.

Career Highlights

Paul Omholt currently serves as an integral part of Trega Biosciences, Inc., where he applies his expertise to develop innovative solutions in the biomedical realm. His career is distinguished by a commitment to improving patient outcomes through research and invention, making substantial contributions to medical science.

Collaborations

Throughout his career, Omholt has collaborated with esteemed colleagues, including Beverly E. Girten and Ronald R. Tuttle. These collaborative efforts have been pivotal in pushing the boundaries of scientific research and enhancing the development of effective medical interventions.

Conclusion

In summary, Paul Omholt is a notable inventor whose work in gastrointestinal health and cytokine regulation showcases the profound impact of innovation in medical treatments. Through his patents and collaborations, he continues to influence the landscape of biomedical research, providing hope for patients dealing with challenging health conditions. His contributions at Trega Biosciences, Inc. enhance the understanding and treatment of conditions that affect many lives globally.